The Manufacturers Life Insurance Company Takes Position in Bruker Corporation $BRKR

The Manufacturers Life Insurance Company acquired a new position in Bruker Corporation (NASDAQ:BRKR) in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 75,380 shares of the medical research company’s stock, valued at approximately $4,536,000.

Several other institutional investors have also recently made changes to their positions in the business. Thrivent Financial for Lutherans grew its holdings in Bruker by 561.3% during the 4th quarter. Thrivent Financial for Lutherans now owns 179,792 shares of the medical research company’s stock valued at $8,470,000 after buying an additional 152,603 shares in the last quarter. Hantz Financial Services Inc. raised its position in shares of Bruker by 202.7% during the fourth quarter. Hantz Financial Services Inc. now owns 41,306 shares of the medical research company’s stock valued at $1,946,000 after buying an additional 27,659 shares during the last quarter. Fifth Third Bancorp lifted its holdings in shares of Bruker by 4,058.3% in the first quarter. Fifth Third Bancorp now owns 57,135 shares of the medical research company’s stock worth $2,064,000 after buying an additional 55,761 shares in the last quarter. Franklin Resources Inc. lifted its holdings in shares of Bruker by 317.7% in the fourth quarter. Franklin Resources Inc. now owns 2,309,404 shares of the medical research company’s stock worth $108,796,000 after buying an additional 1,756,460 shares in the last quarter. Finally, Amundi boosted its position in shares of Bruker by 244.2% during the first quarter. Amundi now owns 62,611 shares of the medical research company’s stock worth $2,261,000 after acquiring an additional 44,421 shares during the last quarter. Hedge funds and other institutional investors own 79.52% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on BRKR. Zacks Research upgraded shares of Bruker from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 4th. Stifel Nicolaus set a $50.00 price objective on shares of Bruker in a report on Wednesday, August 5th. Wolfe Research assumed coverage on Bruker in a research report on Monday, June 1st. They set a “peer perform” rating for the company. UBS Group set a $60.00 target price on Bruker in a research report on Wednesday, June 24th. Finally, Wall Street Zen raised Bruker from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Two equities research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating, four have given a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $56.64.

Bruker Price Performance

Bruker stock opened at $58.01 on Tuesday. Bruker Corporation has a 52-week low of $28.53 and a 52-week high of $65.30. The company has a quick ratio of 0.92, a current ratio of 1.85 and a debt-to-equity ratio of 0.76. The firm’s fifty day moving average is $58.80 and its 200 day moving average is $48.16. The company has a market cap of $8.84 billion, a price-to-earnings ratio of -82.87, a PEG ratio of 1.75 and a beta of 1.28.

Bruker (NASDAQ:BRKR) last issued its quarterly earnings data on Tuesday, August 4th. The medical research company reported $0.49 EPS for the quarter, topping analysts’ consensus estimates of $0.38 by $0.11. Bruker had a negative net margin of 2.35% and a positive return on equity of 12.47%. The business had revenue of $838.50 million during the quarter, compared to analysts’ expectations of $853.57 million. During the same period last year, the company posted $0.32 EPS. The business’s revenue was up 5.2% on a year-over-year basis. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. Sell-side analysts forecast that Bruker Corporation will post 2.12 EPS for the current fiscal year.

Bruker Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 7th. Investors of record on Monday, September 21st will be given a $0.05 dividend. The ex-dividend date is Monday, September 21st. This represents a $0.20 annualized dividend and a yield of 0.3%. Bruker’s dividend payout ratio (DPR) is currently -28.57%.

About Bruker

Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.

Bruker’s product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.

In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.